Pharmacotherapy for Marijuana Dependence: A Double-blind, Placebo-controlled Pilot Study of Divalproex Sodium

References

• Johnston L, O'Malley P, Bachman J.. National Survey Results on Drug Use from the Monitoring the Future Study, 1975-1994. Washington, DC, US Department of Health and Human Services;. 1995
   Google Scholar
• DAWN.. Year End 1998 Report Emergency Room Data from Drug Abuse Network Warning. Washington, DC, US Department of Health and Human Services. 2000
   Google Scholar
• Frank B, Galea J.. Epidemiological trends in drug abuseNIDA U.S. Department of Health and Human Services, NIH1995; II
   Google Scholar
• Tennant F.. The clinical syndrome of marijuana dependence. Psychiatric Annals. 1986; 16: 225–234
   Web of Science ®Google Scholar
• Gallant D., Alcohol. In. Galanter M, HD, Kleber. Textbook of Substance Abuse Treatment. Washington, DC, American Psychiatric Press, Inc. 1999, 151–164
   Google Scholar
• Kranzler HR.. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol. 2000; 35: 537–547
   Web of Science ®Google Scholar
• Kleber HD.. Opioid: detoxification, In. Galanter M, HD, Kleber. Textbook of Substance Abuse Treatment. Washington, DC, American Psychiatric Press, Inc. 1999, 251–269
   Google Scholar
• Stine S, Meandzija B, Kosten T.. Pharmacologic therapies for opioid addiction, In. Graham A, T, Schultz. Principles of Addiction Medicine. Chevy Chase, Md., American Society of Addiction Medicine, Inc. 1998; 545–556
   Google Scholar
• Levin FR, Bisaga A, Kleber HD.. Pharmacological treatments for substance abuse. The Economics of Neuroscience. 2000; 2: 32–40
   Google Scholar
• Gold M.. The pharmacology of marijuana, In. Graham A, T, Schultz. Principles of Addiction Medicine. Chevy Chase, Md., American Society of Addiction Medicine, Inc.. 1998; 163–171
   Google Scholar
• Johns A.. Psychiatric effects of cannabis. Br J Psychiatry. 2001; 178: 116–122. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bensusan AD.. Marihuana withdrawal symptoms. Br Med J. 1971; 3: 112, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Jones RT, Benowitz N, Bachman J.. Clinical studies of cannabis tolerance and dependence. Ann NY Acad Sci. 1976; 282: 221–239. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jones RT, Benowitz NL, Herning RI.. Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol. 1981; 21(8-9 Suppl)143S–152S
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, et al, Abstinence Symptoms Following Oral THC Administration in Humans. Poster. Nashville, Tenn, College on Problems of Drug Dependence. 1997
   Google Scholar
• Fredericks AB, Benowitz NL.. An abstinence syndrome following chronic administration of delta-9- terahydrocannabinol in rhesus monkeys. Psychopharmacology. 1980; 71: 201–202. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, et al, Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl). 1999; 141: 395–404. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, et al, Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl). 1999; 141: 385–394. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nunes EV.. Methodological recommendations for cocaine abuse clinical trials. NIDA Res Monogr. 1997; 175: 73–95. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Stadnicki S, Schaeppi U, Rosenkratz H, et al, Crude marihuana extract: EEG and behavioral effects of chronic oral adrministration in rhesus monkeys. Psychopharmacology. 1974; 37: 225–233. [CROSSREF]
   Google Scholar
• Karler R, Turkanis S.. Cannabis and epilepsy. Marijuana's biological effects: Advances in the biosciences. Proceedings of the Satellite Symposium of the 7th International Congress of Pharmacology, Paris. Oxford, England 1976
   Google Scholar
• McElroy SL, Keck PE, Jr., Pope HG, Jr.. Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol. 1987; 7: 16–24. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• First M, Spitzer R, Gibbon M, et al, Structured Clinical Interview for DSM-IV Axis I Personality Disorders, SCID-II, Version 2.0.. New York, Biometrics Research Department, New York State Psychiatric Institute;. 1994
   Google Scholar
• MacFadden W, Woody GE.. Cannabis-related disorders, In. Sadock B, V, Sadock. Comprehensive Textbook of Psychiatry. Philadelphia, Pa., Lippincott Williams & Wilkins. 2000; 990–999
   Google Scholar
• Guy W.. ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare Publication ADM 76-338. 1976; 217–222
   Google Scholar
• Snaith RP, Taylor CM.. Irritability: definition, assessment and associated factors. Br J Psychiatry. 1985; 147: 127–136. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Lipman RS, Rickels K, et al, The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci.. 1974; 19: 1–15. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• McLellan AT, Luborsky L, Woody GE, et al, An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980; 168: 26–33. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kouri EM, Pope HG, Lukas SE.. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology. 1999; 143: 302–308. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Preston KL, Silverman K, Schuster CR, et al, Use of quantitative urinalysis in monitoring cocaine use. NIDA Res Monogr.. 1997; 175: 253–264. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Smith-Kielland A, Skuterud B. Morland J. Urinary excretion of 11-nor-9-carboxy- delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol. 1999; 23: 323–332. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Budney AJ, Higgins ST, Radonovich KJ, et al, Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol. 2000; 68: 1051–1061. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Budney AJ, Radonovich KJ, Higgins ST, et al, Adults seeking treatment for marijuana dependence: a comparison with cocaine- dependent treatment seekers. Exp Clin Psychopharmacol. 1998; 6: 419–426. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Poddar MK, Bhattacharyya KC, Ghosh JJ.. Potentiating effect of cannabidiol on delta9-tetrahydrocannabinol-induced changes in hepatic enzymes. Biochem Pharmacol. 1974; 23: 758–759. [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Bornheim LM, Correia MA.. Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol. Mol Pharmacol. 1989; 36: 377–383. [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Ketter TA, Frye MA, Cora-Locatelli G, et al, Metabolism and excretion of mood stabilizers and new anticonvulsants. Cellular and Molecular Neurobiology. 1999; 19: 511–532. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cotariu D, Zaidman JL.. Valproic acid and the liver. Clin Chem.. 1988; 34: 890–897. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Keck P, McElroy S.. Antiepileptic drugs, In. Schatzberg A, C, Nemeroff. American Psychiatric Press Textbook of Psychopharmacology. Washington, DC, American Psychiatric Press. 1998; 454
   Google Scholar
• Albanese MJ, Clodfelter RC, Khantzian EJ.. Divalproex sodium in substance abusers with mood disorder. J Clin Psychiatry. 2000; 61: 916–921
   PubMed Web of Science ®Google Scholar
• Mendelson JH, Mello NK, Lex BW, et al, Marijuana withdrawal syndrome in a woman. Am J Psychiatry. 1984; 141: 1289–1290. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Physicians' Desk Reference. Montvale, NJ, Medical Economics Company, Inc. 2000
   Google Scholar
• O'Brien CP. Drug addiction and drug abuse, In. Hardman J, Limbard L. The Pharmacological Basis of Therapeutics. New York, NY, The McGraw-Hill Companies, Inc. 1996; 557–577
   Google Scholar
• Donovan SJ, Stewart JW, Nunes EV, et al, Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry. 2000; 157: 818–820. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Geller B, Cooper TB, Sun K, et al, Double- blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of American Child and Adolescent Psychiatry. 1998; 37: 171–178. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar